Bacteroides thetaiotaomicron and its inactivated bacteria ameliorate colitis by inhibiting macrophage activation

• Published in: Clinics and research in hepatology and gastroenterology 2024-02, Vol.48 (2), p.102276-102276, Article 102276
• Main Authors: Yinhe, Sikong, Lixiang, Li, Yan, Li, Xiang, Gu, Yanqing, Li, Xiuli, Zuo
• Format: Article
• Language: English
• Subjects: Animals; Bacteroides thetaiotaomicron; Colitis; Colitis - chemically induced; Colitis - pathology; Colon - pathology; Disease Models, Animal; Gut microbiota; Inflammation; Inflammatory bowel disease; Interleukin-6 - metabolism; Macrophage; Macrophage Activation; Male; Mice; Mice, Inbred C57BL; RNA, Ribosomal, 16S - metabolism
• ISSN: 2210-7401; 2210-741X
• DOI: 10.1016/j.clinre.2023.102276

•Bacteroides thetaiotaomicron has strong anti-inflammatory effect on colitis.•P38 MAPK signaling pathway in macrophages was strongly inhibited by BT.•Gut microbiota dysbiosis is ameliorated by BT. Studies have demonstrated that Bacteroides thetaiotaomicron (BT) has protective effect against colon inflammation in murine models. Macrophages play an important role in gut immunity. However, the specific mechanisms of BT on macrophage are still unelucidated. Thus, our study investigates the anti-inflammatory effect of BT and its heat-treated inactivated bacteria on experimental colitis and macrophages. A dextran sulfate sodium (DSS)-induced acute colitis model with male C57BL/6 mice, BT (ATCC29148) strain, THP1 cell lines were used in this study. Live and heat-treated inactivated BT (IBT) solution (1 × 10^9cfu/ml) were intragastrically gavaged daily for 14 days. Colonic inflammation was determined by the disease activity index (DAI) score, colon length, histological score, and inflammatory factors. THP1 cells were induced towards M1, then treated with different concentrations of inactivated BT solution and p38 inhibitor. Western blotting, immunohistochemistry, immunofluorescence and qRT-PCR were performed to assess the levels of inflammatory cytokines and molecules of MAPK pathway including IL-6, TNF-α, IL-1β, IL-22, p38 and phosphor-p38 expressions. Moreover, 16S rRNA sequencing of colitis murine fecal samples was applied to investigate the influence of supplementation of BT to the gut microbiota homeostasis. Both live and heat-treated inactivated BT decreased the DAI and histological scores as well as levels of inflammatory factors, particularly IL-6 while increasing IL-22 of DSS-induced colitis murine models. The cell experiments showed that inactivated BT downregulates IL-6 expression in THP1 via inhibiting p38 phosphorylation and affecting M1 polarization. Moreover, the 16S rRNA sequencing results showed that BT and IBT gavage could increase beta-diversity of gut flora in DSS-induced colitis mice. Furthermore, the significance test for differences between the groups showed that BT could increase Faecalebaculum, Lactobacillus and Bacteroides, while decreasing Akkermansia. In summary, our findings imply that BT and its heat-treated inactivated bacteria exert a protective effect by suppressing macrophage-induced IL-6 through the inhibition of p38 MAPK pathway and ameliorating intestinal gut dysbiosis in experimental colitis.